Yield10 Bioscience, Inc. (YTEN) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts YTEN Hot Sheet
Join SI Premium – FREE
Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q1 EPS of ($0.68), in-line with the analyst estimate of ($0.68). Revenue for the quarter came in at $149 thousand versus the consensus estimate of $160 thousand.
For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Meta's capital-raising plans expose a major weakness in the AI boom
- Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
